Targeting PI3Kdelta in Childhood Acute Lymphoblastic Leukemia |
Children’s Hospital Los Angeles / Yong-mi Kim, MD & Nora Heisterkamp, PhD |
Reach Grants |
2015 |
California |
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children’s Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD |
Innovation Grants |
2015 |
California |
Single Cell Analysis of Leukemia Initiation |
Stanford University / Michael Cleary, MD |
Innovation Grants |
2015 |
California |
Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma |
Children’s Hospital Los Angeles / Shahab Asgharzadeh, MD |
Innovation Grants |
2015 |
California |
Targeting Secondary Mutations in Juvenile Myelomonocytic Leukemia |
University of California San Francisco / Elliot Stieglitz, MD |
Young Investigator Grants |
2015 |
California |
Functional Analysis and Therapeutic Targeting of STAG2 Mutations in Ewing sarcoma |
Georgetown University / Todd Waldman, MD, PhD |
Innovation Grants |
2015 |
District of Columbia |
Genetically Modified, Cord Blood Derived Natural Killer Cell Therapy for High Grade Pediatric Brain Tumors |
Children’s Research Institute / Conrad Russell Cruz, MD, PhD |
'A' Award Grants |
2015 |
District of Columbia |
Screen to Intervene: A Family-Centered Approach to Identifying and Communicating Family Psychosocial Risk and Developing Evidence Based Clinical Pathways in Hematopoietic Stem Cell Transplantation |
Alfred I duPont Hospital for Children / Anne Kazak, PhD |
Psychosocial Grants |
2015 |
Delaware |
Novel Role of Hematopoietic Stem Cells in Immunologic Rejection of Malignant Pediatric Brain Tumors |
University of Florida / Catherine Flores, PhD |
Young Investigator Grants |
2015 |
Florida |
The YB1 Way of Surviving Radiation, Pediatric Brain Tumor Resistance and Recurrence |
Emory University / Abhinav Dey, PhD |
Young Investigator Grants |
2015 |
Georgia |